RDCSB618 427 4226
Page 1 of 1
DIGEST
The digest printed below was prepared by House Legislative Services. It constitutes no part
of the legislative instrument. The keyword, one-liner, abstract, and digest do not constitute
part of the law or proof or indicia of legislative intent. [R.S. 1:13(B) and 24:177(E)]
Heitmeier SB No. 618
Present law provides for Carisoprodol as a Schedule IV controlled dangerous substance.
Proposed law amends present law to move Carisoprodol from a Schedule IV to a Schedule
II controlled dangerous substance.
Proposed law provides that wholesale drug distributors licensed by the La. Board of
Pharmacy and registered with the U.S. Drug Enforcement Administration shall be exempt
from the storage, reporting, record keeping, and physical security requirements for any
material, mixture, compound, or preparation which contains any quantity of Carisoprodol.
Effective August 1, 2014.
(Amends R.S. 40:964(Schedule II)(D); Repeals R.S. 40:964(Schedule IV)(B)(4.1))
Summary of Amendments Adopted by House
Committee Amendments Proposed by House Committee on Administration of Criminal
Justice to the engrossed bill.
1. Added an exemption for certain wholesale drug distributors with respect to
certain requirements pertaining to Carisoprodol.